REQUEST A DEMO
Total
USD $0.00
Search more companies

Angelini Pharma Bulgaria EOOD (Bulgaria)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Angelini Pharma Bulgaria EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

CSC Pharmaceutical Bulgaria, which was established in 2000, is primarily engaged in wholesaling pharmaceuticals. The company is part of Italian Angelini S.p.A. It distributes products of major manufacturers from Switzerland, Italy, France, Spain, the USA.

Headquarters
bul. Asen Yordanov 10
Sofia; Sofia - city; Postal Code: 1592

Contact Details: Purchase the Angelini Pharma Bulgaria EOOD report to view the information.

Website: http://www.csc-bg.com/

Basic Information
Total Employees:
Purchase the Angelini Pharma Bulgaria EOOD report to view the information.
Outstanding Shares:
Purchase the Angelini Pharma Bulgaria EOOD report to view the information.
Registered Capital:
Purchase the Angelini Pharma Bulgaria EOOD report to view the information.
Financial Auditors:
Purchase the Angelini Pharma Bulgaria EOOD report to view the information.
Incorporation Date:
November 03, 1992
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Angelini Pharma Bulgaria EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
18.01%
Total operating revenue
17.39%
Operating profit (EBIT)
1475.71%
EBITDA
1342.26%
Net Profit (Loss) for the Period
9.84%
Total assets
-9.92%
Total equity
-24.09%
Operating Profit Margin (ROS)
92.65%
Net Profit Margin
-0.45%
Return on Equity (ROE)
5.59%
Quick Ratio
-0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?